Page last updated: 2024-10-29

iodixanol and Cancer of Ovary

iodixanol has been researched along with Cancer of Ovary in 2 studies

iodixanol: dimeric contrast media; structure given in first source
iodixanol : A dimeric, non-ionic, water-soluble, radiographic contrast agent, used particularly in coronary angiography.

Research Excerpts

ExcerptRelevanceReference
"51 females clinically suspected for ovarian cancer recurrence underwent 3-T WB-DWI/MRI in addition to contrast-enhanced CT."1.43Whole-body diffusion-weighted magnetic resonance imaging in the diagnosis of recurrent ovarian cancer: a clinical feasibility study. ( Amant, F; De Keyzer, F; Dresen, R; Fieuws, S; Leunen, K; Michielsen, KL; Moerman, P; Op de Beeck, K; Vandecaveye, V; Vanslembrouck, R; Vergote, I, 2016)
"The diagnosis of peritoneal carcinomatosis secondary to ovarian cancer is a real challenge in the cancer imaging field."1.36Peritoneal carcinomatosis from ovarian cancer: the role of CT and [¹⁸F]FDG-PET/CT. ( Bellomi, M; Bonello, L; Funicelli, L; Landoni, F; Travaini, LL; Trifirò, G, 2010)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Michielsen, KL1
Vergote, I1
Dresen, R1
Op de Beeck, K1
Vanslembrouck, R1
Amant, F1
Leunen, K1
Moerman, P1
Fieuws, S1
De Keyzer, F1
Vandecaveye, V1
Funicelli, L1
Travaini, LL1
Landoni, F1
Trifirò, G1
Bonello, L1
Bellomi, M1

Other Studies

2 other studies available for iodixanol and Cancer of Ovary

ArticleYear
Whole-body diffusion-weighted magnetic resonance imaging in the diagnosis of recurrent ovarian cancer: a clinical feasibility study.
    The British journal of radiology, 2016, Volume: 89, Issue:1067

    Topics: Adult; Aged; Aged, 80 and over; Biopsy; Contrast Media; Diffusion Magnetic Resonance Imaging; Feasib

2016
Peritoneal carcinomatosis from ovarian cancer: the role of CT and [¹⁸F]FDG-PET/CT.
    Abdominal imaging, 2010, Volume: 35, Issue:6

    Topics: Aged; Carcinoma; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Ovarian Neopla

2010